Skip to main content

PASI-75 with ixekizumab approaches 90% in pediatric psoriasis study

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
PASI-75 with ixekizumab approaches 90% in pediatric psoriasis study

User login

Username

Password

Reset your password

Type	Lead	score